Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The human eosinophil in inflammation.

P Venge1

  • 1Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.

Agents and Actions
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Eosinophils are potent inflammatory cells releasing cytotoxic proteins and mediators. Understanding eosinophil attraction to inflammation sites is key to controlling their activity in diseases like asthma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary neutrophil gelatinase-associated lipocalin to hepcidin ratio as a biomarker of acute kidney injury in intensive care unit patients.

Minerva anestesiologica·2014
Same author

Cationic proteins of human granulocytes: Enhancement of phagocytosis ofStaphylococcus protein A-IgG complexes.

Inflammation·2013
Same author

Cationic proteins of human granulocytes Effects on human platelet aggregation and serotonin release.

Inflammation·2013
Same author

Multicenter analytical evaluation of a high-sensitivity troponin T assay.

Clinica chimica acta; international journal of clinical chemistry·2011
Same author

Gastrointestinal sensitivity to soy and milk proteins in patients with IgA nephropathy.

Clinical nephrology·2010
Same author

Self-reported food intolerance and mucosal reactivity after rectal food protein challenge in patients with rheumatoid arthritis.

Scandinavian journal of rheumatology·2010
Same journal

Classification and biological distribution of histamine receptor sub-types. 1975.

Agents and actions·1994
Same journal

Metiamide--an orally active histamine H2-receptor antagonist. 1973.

Agents and actions·1994
Same journal

A brief survey of the history of inflammation. 1978.

Agents and actions·1994
Same journal

The discovery of librium. 1972.

Agents and actions·1994
Same journal

Notes and documents concerning the discovery of LSD. 1970.

Agents and actions·1994
Same journal

Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

Agents and actions·1994
See all related articles

Area of Science:

  • Immunology and Cellular Biology
  • Inflammatory Processes

Background:

  • Eosinophils are recognized as key inflammatory cells involved in numerous disease processes.
  • Their inflammatory activity is driven by the release of cytotoxic proteins (e.g., ECP, EPO, EPX/EDN, MBP) and mediators (e.g., LTC4, PAF).

Purpose of the Study:

  • To highlight the significant role of eosinophils in inflammatory conditions.
  • To emphasize the link between eosinophil accumulation, protein secretion, and tissue damage.
  • To underscore the importance of identifying eosinophil chemoattractants for therapeutic strategies.

Main Methods:

  • Review of recent research on eosinophil function and inflammatory processes.
  • Analysis of studies demonstrating eosinophil cytotoxic potential in various diseases.

Related Experiment Videos

  • Examination of measurements of eosinophil proteins in body fluids as indicators of disease activity.

    • Main Results:

    • Eosinophil accumulation and secretion of granule proteins are associated with tissue injury in inflammatory diseases.
    • Elevated levels of eosinophil proteins in bodily fluids confirm their active role in conditions like asthma and rheumatoid arthritis.
    • The cytotoxic potential of eosinophils is well-established in disease pathogenesis.

    Conclusions:

    • Eosinophils are potent effector cells in inflammatory diseases.
    • Identifying the factors that recruit eosinophils to inflammation sites is crucial for developing targeted therapies.
    • Controlling eosinophil activity holds therapeutic promise for a range of inflammatory conditions.